Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 38238005.
- Also identified by DOI 10.1136/thorax-2023-220076 and PMC identifier 10923134.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated phenotypic leucocyte telomere length (LTL), genetically predicted LTL (gTL), and lung cancer risk among 371 890 participants, including 2829 incident cases, from the UK Biobank. Using multivariable Cox regression, we found dose-response relationships between longer phenotypic LTL (p-trend<sub>continuous</sub>=2.6×10<sup>-5</sup>), longer gTL predicted using a polygenic score with 130 genetic instruments (p-trend<sub>continuous</sub>=4.2×10<sup>-10</sup>), and overall lung cancer risk, particularly for adenocarcinoma. The associations were prominent among never smokers. Mendelian Randomization analyses supported causal associations between longer telomere length and lung cancer (HR<sub>per 1 SD gTL</sub>=1.87, 95% CI: 1.49 to 2.36, p=4.0×10<sup>-7</sup>), particularly adenocarcinoma (HR<sub>per 1 SD gTL</sub>=2.45, 95%CI: 1.69 to 3.57, p=6.5×10<sup>-6</sup>).
Medical subject headings
- Lung Neoplasms
- Adenocarcinoma